RE:New Press Release - Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) FY25 Q1 This arrives at a valuation range of $1.96 to $2.43 with a mid-point of $2.16. ------------------ and this ofc WITHOUT Merit !!!
___when Merit comes back it will be a sp target far upper part of Q+A concerning Merit
Kip Underwood: Thanks, Dan. So first, I'll take the merit question. So the Merit business, as it stands, ceased to operate in March of 2023 and has not operated since. Now, that being said, the assets of the Merit business are still for sale. I stay in contact with the receiver who's managing the process. And what we believe for the Merit assets, resolution to that situation is good for us. And it can be good for us in three different ways. First is, if there's an opportunity for us to buy them at the right price that is better than our current model, we can take advantage of that. Second, if somebody, if another entity bought the assets, they are still purpose-built for our process, we could further leverage our capitalized business model and contract manufacturer in that facility. Or third, if somebody purchased the facility, did not want to run our product, maybe there's an opportunity for us to go in and buy some of the equipment we could use elsewhere. So regardless of how the merit situation turns out, we see that as accretive to our overall plan. The key piece is we're not in control of the timeline of the process though. That's why we have our capitalized business model that we execute independently.
source: investing.com